Post Tagged with: "AGEN"

Stocks Swings: Zoetis Inc. (NYSE:ZTS), Cnova N.V. (NASDAQ:CNV), Agenus Inc. (NASDAQ:AGEN), Trade Street Residential (NASDAQ:TSRE), First Horizon National Corporation (NYSE:FHN)

February 12, 2015 at 1:08 pm 0 comments

Zoetis Inc. (NYSE:ZTS) reported revenue of $1.3 billion for the 2014 fourth quarter, an increase of 5% from the 2013 fourth quarter; revenue reflected an operational increase of 9%, excluding the impact of foreign currency. Net income for the fourthRead More

5 Stocks in Dramatic Moves: Agenus Inc. (NASDAQ:AGEN), Glu Mobile (NASDAQ:GLUU), CRA International Inc. (NASDAQ:CRAI), Napco Security Technologies (NASDAQ:NSSC), USLM

February 9, 2015 at 1:23 pm 0 comments

Agenus Inc. (NASDAQ:AGEN) announced that the Company will present at the 17th Annual BIO CEO & Investor Conference on Monday February 9th at 4:30 p.m. Eastern Time. On Friday shares of Agenus Inc. (NASDAQ:AGEN) closed at $4.68. Company’s sales growthRead More

Biotech Bears: CytRx Corporation (NASDAQ:CYTR), Can-Fite BioPharma (NYSEMKT:CANF), Avalanche Biotechnologies (NASDAQ:AAVL), Genetic Technologies Limited (NASDAQ:GENE), Agenus Inc. (NASDAQ:AGEN)

January 26, 2015 at 1:26 pm 0 comments

CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical research and development company specializing in oncology, announced encouraging overall survival (OS) results, the secondary endpoint, from its completed multicenter, randomized, open-label global Phase 2b clinical trial investigating the efficacy and safety of aldoxorubicin comparedRead More

Top Stocks: Radio One Inc. (NASDAQ:ROIAK), Cypress Semiconductor Corporation (NASDAQ:CY), Agenus Inc. (NASDAQ:AGEN), Lululemon Athletica Inc. (NASDAQ:LULU), Essex Property Trust Inc. (NYSE:ESS)

January 25, 2015 at 2:36 pm 0 comments

Radio One, Inc. (NASDAQ: ROIAK) will be holding a conference call for investors, analysts and other interested parties to discuss its results for the fiscal year 2014. The conference call is scheduled for Thursday, February 12, 2015 at 10:00 a.m.Read More

Biotech Insider Selling to Watch: Agenus Inc. (NASDAQ:AGEN), BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), bluebird bio (NASDAQ:BLUE), Vical Incorporated (NASDAQ:VICL), Sangamo Biosciences (NASDAQ:SGMO)

January 15, 2015 at 2:32 pm 0 comments

Agenus (NASDAQ:AGEN) major shareholder Qvt Associates Gp Llc sold 2,343,630 shares of Agenus stock on the open market in a transaction dated Friday, January 9th. The shares were sold at an average price of $5.31, for a total transaction ofRead More

Market Wrap Up: Esperion Therapeutics (NASDAQ:ESPR), Agenus Inc. (NASDAQ:AGEN), Entropic Communications (NASDAQ:ENTR), IPG Photonics Corporation (NASDAQ:IPGP), Peapack-Gladstone Financial Corp. (NASDAQ:PGC)

January 15, 2015 at 12:55 pm 0 comments

Equities researchers at JMP Securities hoisted their price target on shares of Esperion Therapeutics, Inc (NASDAQ:ESPR) from $53.00 to $75.00 in a research report issued on Monday. The firm currently has an “outperform” rating on the stock. JMP Securities’ priceRead More

Ever Green Stocks: Agenus Inc. (NASDAQ:AGEN), CSX Corp. (NYSE:CSX), Symantec Corporation (NASDAQ:SYMC), Google Inc (NASDAQ:GOOG), Jive Software (NASDAQ:JIVE)

January 14, 2015 at 2:45 pm 0 comments

Agenus (NASDAQ:AGEN) major shareholder Qvt Associates Gp Llc sold 2,343,630 shares of the stock on the open market in a transaction dated Friday, January 9th. The stock was sold at an average price of $5.31, for a total transaction ofRead More

Biotech Insider Selling: BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Revance Therapeutics (NASDAQ:RVNC), Aratana Therapeutics (NASDAQ:PETX), Agenus Inc. (NASDAQ:AGEN), Albany Molecular Research (NASDAQ:AMRI)

January 14, 2015 at 2:04 pm 0 comments

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) CEO Jean Jacques Bienaime sold 2,000 shares of BioMarin Pharmaceutical stock in a transaction that occurred on Friday, January 9th. The shares were sold at an average price of $94.14, for a total transaction of $188,280.00.Read More

Healthcare Losers in news: Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Agenus Inc. (NASDAQ:AGEN), Arrowhead Research Corp. (NASDAQ:ARWR), Tekmira Pharmaceuticals Corp. (NASDAQ:TKMR), Orexigen Therapeutics (NASDAQ:OREX)

January 14, 2015 at 2:01 pm 0 comments

Ariad Pharmaceuticals Inc (NASDAQ:ARIA) announced its key strategic objectives for 2015, details of which will be presented at the 33rd Annual J.P. Morgan Healthcare Conference on January 14, 2015 in San Francisco, California. On Tuesday shares of Ariad Pharmaceuticals Inc.Read More

Biotech Bearish Stocks: TrovaGene (NASDAQ:TROV), Agenus Inc. (NASDAQ:AGEN), Juno Therapeutics Inc. (NASDAQ:JUNO), BIND Therapeutics (NASDAQ:BIND), Ariad Pharmaceuticals Inc. (NASDAQ:ARIA)

January 14, 2015 at 2:01 pm 0 comments

On 6 January TrovaGene, Inc. (NASDAQ:TROV) announced that Carl Feldbaum, president emeritus of the Biotechnology Industry Organization (BIO), the world’s largest biotechnology trade association, has been appointed to its board of directors. He will also serve as chairman of theRead More